Company
Pharmaron
Pharmaron is a contract research organization providing drug discovery, development, and manufacturing services to pharmaceutical and biotechnology companies. The company offers laboratory services spanning chemistry, analytical sciences, and toxicology testing, alongside manufacturing capabilities for small molecules and biologics. Pharmaron also provides clinical development support and specialized services including radiolabeled compound studies and cell and gene therapy development.
Pharmaron is a publicly traded company operating in the pharmaceutical industry sector, based in China. It trades on the Shenzhen Stock Exchange under the ticker 300759. Leadership tracked by CEOInsider includes Boliang Lou (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Pharmaron's significant expansion efforts across multiple geographies and manufacturing capabilities. The company has undertaken a series of acquisitions and facility developments, including a major site expansion at its Liverpool gene therapy facility supported by UK government funding, as well as acquisitions of manufacturing and bioprocessing sites in the United States and United Kingdom. These moves reflect Pharmaron's strategy to grow its contract research, manufacturing, and development operations internationally while strengthening its presence in gene therapy and API production.
Summarized from the headlines in the sidebar; see each source for the full story.